In Vivo is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


From Device Centric To Disease Management: Ascensia Commits To Deeper Role In Diabetes

Executive Summary

Ascensia is pushing back the borders of diabetes control, using its legacy BGM technology as a business platform to move into CGM en route to becoming a one-stop-shop for diabetes management solutions. A significant step toward these goals was taken in January, when the Swiss group completed a key China deal with a local CGM innovator, as chief marketing and strategy officer Martin Lange explained to In Vivo.






Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts